Clinical Trials Directory

Trials / Unknown

UnknownNCT03563924

Allo - Cancer - Thrombosis

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Management of venous thromboembolism (VTE) in patients with cancer is complex and require the intervention of many specialized health professionals, in hospital but also at home and during follow-up. The AlloTC project aims to integrate the management of VTE within the multidisciplinary care pathway of the patient with cancer, in order to improve the management of VTE in patients with cancer: optimize treatments and follow-up with appropriate anticoagulants, monitor the implementation of good clinical practice, promote patient involvement and adherence. The objective of this monocentric study is to evaluate the efficiency of the integration of the therapeutic management of VTE into a specific management of patient with cancer and to set up a specialized "AlloTC" team that coordinates this course of care. For that purpose, the management of VTE and outcome of patients with cancer and VTE will be compared between two periods : traditional management and management with the "AlloTC" team.

Conditions

Interventions

TypeNameDescription
OTHERSetting up a specific care path "AlloTC" for management of TVE in patients with cancerSetting up a specific care path "AlloTC" for management of TVE in patients with cancer with a specific coordination nurse within the "AlloTC" multidisciplinary team as a privileged interlocutor for health professionals and patients with the aim of simplifying the care pathways and ensuring a hospital-city interface organized in collaboration with the attending physician, to develop and publicize tools available for patients and caregivers (information documents, patient monitoring protocols, etc.)

Timeline

Start date
2018-06-01
Primary completion
2018-12-01
Completion
2019-09-01
First posted
2018-06-20
Last updated
2018-06-20

Source: ClinicalTrials.gov record NCT03563924. Inclusion in this directory is not an endorsement.